DRUG · Mapped RxNorm record
exemestane
Normalized identity: exemestane View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer
NCT00810797
Study summary
ClinicalTrials.govExemestane in Treating Postmenopausal Women With Stage IV Breast Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
quality-of-life assessment
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
immunohistochemistry staining method
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
exemestaneDRUG · verified · RxNorm: exemestane
quality-of-life assessmentPROCEDURE
Sponsors & collaborators
City of Hope Medical Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00810797 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.